Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Rivas Medical Weight Loss vs Willow

Rivas Medical Weight Loss
Graded #437

Lower grade

vs+2.6000000000000014
Willow
Graded #377

Higher grade

The verdict

Willow takes it — 58.2/100 to 55.6/100.

Willow grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider offering compounded GLP-1 medications in both tablet and injectable formats.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRivas Medical Weight Loss +9
45
36
Dose & formulationWillow +35
40
75
Clinical oversightRivas Medical Weight Loss +10
81
71
Labs & monitoringRivas Medical Weight Loss +1
53
52
FulfillmentEven
65
65
Contract termsEven
55
55
Rivas Medical Weight Loss · left barWillow · right bar

The numbers

MetricRivas Medical Weight LossWillow
WeighScore55.6/10058.2/100
GradeCC
Scorecard rank#437#377
SemaglutideNot disclosed$299/mo (starting dose, compounded)
TirzepatideNot disclosed$399/mo (starting dose, compounded)
Coverage3 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes

Strengths

  • Physician-founded (Paul Rivas MD) with 15 clinics plus telehealth
  • Flat price for any dose; weekly provider visits included in every payment
  • Offers both compounded semaglutide and tirzepatide

Where it loses points

  • Expensive: about $498/mo for semaglutide and $715/mo for tirzepatide (billed weekly)
  • Only available in Maryland, Virginia, and Florida
  • Weekly-visit concierge model requires more frequent engagement than mail-order
Willow

Graded #377 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard